Cavitation Technologies Sells Patents to Desmet, Focuses on Water Treatment
TL;DR
CTi signed an agreement with Desmet Group, SA, which provided necessary capital through patent sales.
CTi sold some intellectual property rights related to vegetable oil refining to Desmet, receiving $1.1 million in cash and forgiveness of $400,000 in advances.
CTi's water treatment technology reduces operational costs and promotes sustainable farming practices, improving water quality and supporting healthier crop growth.
CTi has developed HydroPlasma, a technology combining cavitation and cold plasma to enhance water treatment efficiency, with multiple industrial applications.
Found this article helpful?
Share it with your network and spread the knowledge!
Cavitation Technologies, Inc. (CTi), a nano-technology systems manufacturer, has sold several patents related to vegetable oil refining to Desmet Group, SA for approximately $1.1 million in cash and $400,000 in debt forgiveness. This strategic move allows CTi to focus on its water treatment and beverage enhancement technologies while avoiding dilution of existing shareholders.
Under the agreement, CTi retains exclusive rights to use the patents and trademarks in water processing, wastewater treatment, and alcoholic beverage production. The company will continue to own and operate a large portfolio of patents in applications unrelated to vegetable oil refining.
CTi is currently pursuing opportunities in water remediation, particularly in the Permian Basin oil fields and agricultural sector. The company has installed a system at a major water remediation company in Texas and is conducting trials at Hacienda Farms in Canada to improve water quality for greenhouse operations.
The company's water treatment technology offers several advantages, including chemical-free operation, rapid integration into existing processes, and compact, energy-efficient systems. These features position CTi to compete in the growing water treatment market, which is valued at $2.51 billion in Canada alone.
CTi has also developed a new technology called HydroPlasma, which combines cavitation and cold plasma for enhanced water treatment efficiency. This innovation has potential applications in various industries and aligns with the projected growth of the global cold plasma market, expected to reach $3.1 billion by 2027.
Despite facing challenges in the micro-cap market and limited access to capital, CTi's CEO remains optimistic about the company's future, citing its unique technologies and potential for growth in water treatment and remediation applications. The company's strategic focus on these areas, along with its partnerships in beverage technology, positions it to pursue multiple opportunities in expanding markets.
Curated from NewMediaWire
